【レポートの概要（一部）】
1. Report Overview
1.1 The OTC Pharmaceuticals Market Overview
1.2 OTC Pharmaceuticals Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to OTC Pharmaceuticals
2.1 What Are OTC Pharmaceuticals?
2.2 Classification of OTC Pharmaceuticals
2.3 What are the Requirements for an OTC Pharmaceutical Drug?
2.4 OTC Switching
2.4.1 How Is a Drug Switched from Prescription to OTC?
2.5 Manufacturing and Distribution of OTC Pharmaceuticals
2.6 Regulation of OTC Pharmaceuticals
2.6.1 Regulation of OTC Pharmaceuticals in the US
2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
2.6.3 Regulation of OTC Pharmaceuticals in Europe
2.6.4 Regulation of OTC Pharmaceuticals in China
2.6.5 Regulation of OTC Pharmaceuticals in Others Countries
2.7 OTC Pharmaceuticals: Market Segmentation
2.7.1 Analgesics
2.7.1.1 Internal Analgesics
2.7.1.2 External Analgesics
2.7.2 Cough, Cold and Allergy Products
2.7.2.1 Cough and Cold Remedies
2.7.2.2 Anti-Allergy Products
2.7.3 Dermatological Products
2.7.3.1 Minor Cuts and Wounds
2.7.3.2 Acne
2.7.3.3 Rashes, Itchy Skin, and Dermatitis/Eczema
2.7.3.4 Cold Sores
2.7.3.5 Warts
2.7.3.6 Fungal Skin Infections
2.7.3.7 Haemorrhoids
2.7.3.8 Other Dermatological Products
2.7.4 Gastrointestinal Products
2.7.4.1 Indigestion and Heartburn
2.7.4.2 Anti-Diarrhoea OTC Pharmaceuticals
2.7.4.3 Laxatives
2.7.4.4 Anti-Emetic OTC Pharmaceuticals
2.7.4.5 Anti-Obesity OTC Pharmaceuticals
2.7.5 Eye Care
2.7.5.1 Dry Eye Syndrome
2.7.5.2 Bacterial Conjunctivitis
2.7.5.3 Ocular Allergy and Allergic Conjunctivitis
2.7.5.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
2.7.6 Smoking Cessation Aids
2.7.7 Other OTC Products
2.7.8 Vitamins, Minerals and Supplements
3. The World OTC Pharmaceutical Market 2016-2026
3.1 The World OTC Pharma Market in 2014 and 2015
3.1.1 OTC Pharma Market Segmentation in 2015 and 2016
3.1.2 Leading OTC Pharma Brands
3.1.3 Leading Companies in the OTC Market in 2014 and 2015
3.2 The World OTC Pharma Market: Sales Forecast 2016-2026
3.2.1 The World OTC Pharma Market, 2016-2026: Drivers and Restraints
3.3 OTC Pharma Market Segments: Sales Forecasts, 2016-2026
3.3.1 CAGRs by OTC Segment, 2015-2025
3.3.2 Changing Market Shares by OTC Segment, 2016-2026
3.3.3 Cough, Cold and Allergy OTC Market: Sales Forecast 2016-2026
3.3.4 Analgesics OTC Market: Sales Forecast 2016-2026
3.3.5 Gastrointestinal OTC Market: Sales Forecast 2016-2026
3.3.6 Dermatological OTC Market: Sales Forecast 2016-2026
3.3.7 Eye Care OTC Market: Sales Forecast 2016-2026
3.3.8 Smoking Cessation OTC Market: Sales Forecast 2014-2026
3.3.9 Other OTC Market: Sales Forecast 2016-2026
4. The Leading National Markets 2016-2026
4.1 Regional Breakdown of the World OTC Pharma Market in 2014 and 2015
4.2 The World OTC Pharmaceutical Market: Regional Forecast 2016-2026
4.3 Changing Market Shares of Leading National Markets: Emerging Dominance of China
4.4 The US OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.4.1 The US OTC Pharma Market: Financial Incentives to Using OTC Drugs
4.4.2The US OTC Pharma Market: Leading Companies
4.5 The Japanese OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.5.1 The Japanese OTC Pharma Market: Deregulation could Stimulate Growth
4.5.2The Japanese OTC Pharma Market: Leading Companies
4.6 The EU5 OTC Pharma Market in 2014 and 2015
4.6.1 Changing Market Shares of the EU5 OTC Pharmaceuticals Market
4.6.2 The EU5 OTC Market Sales Forecast, 2016-2026
4.6.3 The EU5 OTC Pharma Market: Leading Companies
4.6.4 The German OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.6.5 The UK OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.5.1 The UK’s Liberal OTC Regulations
4.6.6 The French OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.6.6.1 OTC Drugs: A French Monopoly System
4.6.7 The Italian OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.8 The Spanish OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.7 The Chinese OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.7.1 The Chinese OTC Pharma Market: Leading Companies
4.7.2 The Role of Traditional Chinese Medicines (TCM) in the Chinese OTC Market
4.8 The Brazilian OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.8.1 The Brazilian OTC Pharma Market: An Overview
4.9 The Russian OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.9.1 The Russian OTC Pharma Market: Overview
4.10 The Indian OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.10.1 The Indian OTC Pharma Market: An Overview
4.11 The Mexican OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.12 The Rest of the World OTC Pharmaceutical Market Sales Forecast, 2016-2026
5. Leading Companies in the OTC Pharma Market 2016-2026
5.1 Leading OTC Pharmaceutical Manufacturers, 2015
5.1.1 Leading OTC Pharmaceutical Manufacturers after completed Transactions, 2015
5.2 GSK
5.2.1 GSK Consumer Healthcare Unit: Historical Activity
5.2.2 GSK Consumer Healthcare Formed by a Joint-Venture Undertaken by GSK and Novartis
5.2.3 GSK/Novartis: Additional Transactions
5.2.4 GSK Consumer Healthcare: OTC Sales Forecast, 2015-2026
5.2.5 Flonase Launched in US
5.2.6 Panadol
5.2.7 Voltaren Gel
5.2.7.1 Voltaren Gel: Sales Forecast 2015-2025
5.2.8 Alli: A Beleaguered Brand
5.2.9 GSK Smoking Cessation Products
5.3 Novartis (OTC Joint Venture with GSK)
5.3.1 Novartis: Transformational Year
5.4 Bayer
5.4.1 Acquisition of Merck’s Consumer Care Business, 2014
5.4.2 Bayer Acquires Dihon in 2014
5.4.3 Bayer: OTC Sales Forecast, 2014-2025
5.4.4 Bayer Aspirin
5.4.5 Bayer Aspirin: Sales Forecast 2016-2026
5.4.6 Claritin OTC (Loratadine)
5.5 Merck & Co (Consumer Care Segment Acquired by Bayer)
5.6 Johnson and Johnson
5.6.1 FDA Governance of McNeil Manufacturing Activity
5.6.2 Johnson & Johnson: OTC Sales Forecast, 2014-2026
5.6.3 Rhinocort Allergy Spray
5.6.4 Tylenol
5.6.5 Nicorette
5.7 Perrigo
5.7.1 Perrigo: OTC Sales Forecast, 2014-2026
5.7.2 Perrigo Benefits from Challenges Faced by J&J
5.7.3 Perrigo: Growth by Acquisition
5.7.4 Perrigo Acquires Omega Pharma
5.7.5 Perrigo Acquires GSK Portfolio
5.7.6 Perrigo Expands Mexican Capacity and Capabilities
5.7.7 Mylan’s Hostile Takeover Bid
5.8 Pfizer
5.8.1 Pfizer: OTC Sales Forecast, 2015-2025
5.8.2 Pfizer Announces Merger with Allergan
5.8.3 Pfizer Acquires Rights to AstraZeneca’s OTC Nexium
5.8.4 Pfizer: Bulking up Their OTC Product Portfolio
5.8.5 Advil
5.9 Procter & Gamble
5.9.1 PGT Healthcare- Procter& Gamble’s Joint Venture with Teva
5.9.2 Prilosec OTC
5.9.3 Major Plans for Divestment Including OTC Products
5.10 Reckitt Benckiser
5.10.1 Reckitt Benckiser: OTC Sales Forecast, 2014-2026
5.10.2 Internal Growth by “Power” Brand Extensions: Mucinex
5.10.3 Expanding Presence in Emerging Markets through Acquisition
5.11 Sanofi
5.11.1 Sanofi Focuses on Long-Term Growth with Potential Boehringer Ingelheim Asset Swap Pending Completion Q4 2016
5.11.2 Sanofi: Acquisition of OTC Products from J&J
5.11.3 Sanofi: Launch of Nasacort
5.11.4 Sanofi: OTC Sales Forecast, 2014-2026
5.12 Boehringer Ingelheim
5.12.1 Boehringher Ingelhime: OTC Sales Forecast 2014-2026
5.13. Mylan Enter OTC Market
6. OTC Switching and Potential Future of OTC Drugs
6.1 OTC Switching: An Overview
6.1.1 What is OTC Switching?
6.1.2 Which Products Will Switch?
6.1.3 How Does OTC Switching Occur?
6.1.4 How Does OTC Switching Affect the OTC Pharma Market?
6.1.5 Opposition to OTC Switching
6.2 OTC Switching Activity, 2002-2015
6.2.1 OTC Switching: Downward Trend
6.2.2 The FDA NSURE Initiative: Reversing the Downward Trend in Rx-to-OTC Switches
6.3 Potential Candidates for OTC Switching 2016-2026
6.4 Cough, Cold and Allergy: OTC Switches
6.4.1 First-Generation Antihistamines
6.4.2 Allegra (fexofenadine)
6.4.3 Clarinex (desloratadine)
6.4.4 Rhinocort Allergy Spray (budesonide): Latest Nasal Corticosteroid Approval
6.4.5 Flixotide/Flonase (fluticasone): Latest Nasal Corticosteroid Approval
6.4.6 Nasacort (triamcinolone): First in Class U.S. OTC Approval
6.5 Analgesics: OTC Switch Limitations
6.5.1 Triptans: The U.S. Will Remain Cautious
6.5.2 NSAIDs for Arthritis: Safety Concerns Incites Reverse-Switching
6.5.3 Other Analgesics
6.6 Gastrointestinals: OTC Switches
6.6.1 H2-Receptor Blockers
6.6.2 Proton Pump Inhibitors (PPIs)
6.6.2.1 Omeprazole
6.6.2.2 Lansoprazole
6.6.2.3 Pantoprazole
6.6.2.4 Esomeprazole: 2014 U.S. FDA Approval for OTC Use
6.6.2.5 Rabeprazole
6.6.3 Anti-Obesity Drugs
6.7 Dermatologicals: OTC Switches
6.7.1 Antivirals for Oral Herpes Simplex
6.8 Anticholinergics for Incontinence: OTC Switches
6.9 Oral Contraceptives: An OTC Switch Can have Significant Economic Benefits
6.10 High Demand for OTC Cholesterol-Lowering Drugs
6.10.1 Lipitor (atorvastatin): Testing Times for Pfizer
6.10.2 Zocor Heart Pro (simvastatin) in the UK
6.10.3 OTC Statins: U.S. Historical Setbacks
6.11 Other Potential OTC Switch Categories
6.11.1 High Blood Pressure: Thiaside Diuretics
6.11.2 Erectile Dysfunction: Viagra (sildenafil), Cialis (tadalafil)
6.11.3 Osteoporosis: (Bisphosphonates) An Undertreated Disease, but a Very Unlikely OTC Switch
6.11.4 Insomnia: Silenor (doxepin)
7. Qualitative Analysis of the OTC Pharma Market, 2016-2026
7.1 SWOT Analysis of the OTC Pharmaceutical Market
7.2 Strengths
7.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
7.2.1.1 Manufacturers Can Reap OTC Sales Benefits
7.2.1.2 Third Party Payers: Reducing the Cost Burden
7.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer
7.2.2 Many Pharma Companies Have a Strong Potential OTC Portfolio
7.2.3 Regulators Are Encouraging OTC Approvals
7.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
7.2.5 Deterring the Consumption of Counterfeit Drugs
7.2.6 Cultural Changes Will Support Self-Medication with OTC Medicines
7.3 Weaknesses
7.3.1 Pharma Companies Remain Focused on Prescription Drugs
7.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
7.3.3 OTC Products are Vulnerable to Price Controls by Governments
7.3.4 Downward Cost Pressures of OTC Drugs
7.4 Opportunities
7.4.1 Demographic and Economic Changes Will Create Growth Opportunities
7.4.2 New OTC Switch Categories
7.4.3 Strong Growth in Emerging Markets
7.4.4 New Healthcare Technologies May enable OTC Approvals
7.4.5 Opportunities to Drive Sales via Social Media and Online Marketing
7.4.6 Self Medication can Reduce the Under Treatment of Disease
7.5 Threats
7.5.1 Competition from Private-Label Brands Will Reduce Profitability
7.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
7.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
7.6 Porter’s Five Forces Analysis of the OTC Pharmaceutical Market
7.6.1 Rivalry Among Competitors [High]
7.6.2 Threat of New Entrants [Medium]
7.6.3 Power of Suppliers [Low]
7.6.4 Power of Buyers [Medium]
7.6.5 Threats of Substitutes [Medium]
8. Conclusions
8.1 The World OTC Pharma Market in 2014-2015
8.1.1 The Leading OTC Product Categories
8.1.2 Leading OTC Pharma Brands, 2015
8.1.3 Leading OTC Manufacturers
8.1.4 Leading National Markets: Emerging Market Represent a Large Proportion
8.1.5 The Global OTC Market Growth Factors
8.1.6 Potential OTC Switching, 2016-2026
8.1.7 Emerging OTC Markets
8.2 Concluding Remarks
Appendices
Visiongain’s Bespoke Research Service
Some Associated Reports
Visiongain Report Sales Order Form
About Visiongain
Report Evaluation Form
【レポート販売概要】
■ タイトル：OTC医薬品（市販薬）の世界市場予測2016-2026■ 英文：World OTC Pharmaceutical Market Forecast 2016-2026
■ 発行日：2016年3月
■ 調査会社：visiongain
■ 商品コード：VGAIN6041529
■ 調査対象地域：グローバル
- 黒鉛電極の世界市場2016-2020About Graphite Graphite is a crystalline form of carbon, which is a semimetal and a native element mineral. It is considered as one of the allotropes of carbon, and has distinct structure and properties. Graphite is the highest grade of coal, and has stable form of carbon under standard conditions. It has characteristics of metal and non-metal with high thermal and electrical conductivity. It is h …
- ミオクローヌス発作治療のグローバル臨床試験動向（2014年H2）Myoclonic Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Myoclonic Seizures Global Clinical Trials Review, H2, 2014" provides data on the Myoclonic Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonic Seizures. It includes an overview of the trial numbers and their recruitme …
- 自動車用ダイナミックステアリング装置の世界市場2017-2021About Automotive Dynamic Steering System An automotive dynamic steering system is an advanced system that alters or modifies the characteristics of steering system to adapt to the present vehicle speed and on-road conditions. The advanced steering response or control system aids in better handling by providing adequate feedback of the road and adjusting itself as per the road conditions. The syste …
- 世界の予測分析市場（不正行為、詐欺、リスク、マーケティング、オペレーション）The surging competition across various industry verticals need to look out for newer technologies to maintain their foothold in the ever-changing market. Regardless of the industry type and organizational size, big data is generated with every instance of consumer interaction. Predictive analytics ensures that this big data is scrutinized and correlated with present and past historical trends, to …
- 音楽ストリーミングサービスの世界市場2015-2019About Music Streaming Service Streamed music refers to a service that enables users to stream and listen to music/songs using a device connected to the Internet. Service providers purchase digital rights from music recording companies and based on the subscription type, users can access tracks listed on the service provider's application and website. Many service providers offer online radio strea …
- コンピューター統合生産（CIM)の世界市場2018-2022About Computer Integrated Manufacturing CIM is the integration of manufacturing process, with the help of computers. CIM is a broad concept and includes designing, manufacturing, management, and several other business processes associated with manufacturing. Technavio’s analysts forecast the global computer integrated manufacturing market to grow at a CAGR of 7.02% during the period 2018-2022. Cov …
- 洞不全症候群：治療薬のグローバル治験動向（2014年下半期）Sick Sinus Syndromes Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Sick Sinus Syndromes Global Clinical Trials Review, H2, 2014" provides data on the Sick Sinus Syndromes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sick Sinus Syndromes. It includes an overview of the trial numbers and their r …
- スペインの癌診断・検査市場2014This report provides an overview of the Spanish cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Table of ContentsBusiness EnvironmentMarket StructureMarket Size, Growth, and Major Suppliers' Market SharesList of TablesTest Volume Forecasts by Market Segment …
- 急性心不全：治療薬のグローバル治験動向（2014年下半期）Acute Heart Failure Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Acute Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Heart Failure. It includes an overview of the trial numbers and their recru …
- エンタープライズサイバーセキュリティの世界市場展望2017-20276According to Stratistics MRC, the Global Enterprise Cyber Security Market is accounted for $3.35 billion in 2017 and is expected to reach $17.65 billion by 2026 growing at a CAGR of 20.3% during the forecast period. Some of the key factors influencing the market growth include increasing adoption of cloud-based services and an increase in the frequency and sophistication of cyber threats. However, …
- Gulfport Energy Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Gulfport Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Gulfport Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 住宅向け水処理装置の世界市場2016-2020：POU、POEAbout Residential Water Treatment Equipment Water treatment is the practice of converting used or polluted water to a safe, usable state and making it suitable for different applications. This practice consists of methods that remove unwanted elements and add essential elements. Different water treatment equipment converts the wastewater into potable water that is acceptable for many applications. …
- 発電業界のM&A及び投資動向（月別）：July 2013Power Monthly Deal Analysis - July 2013: M&A and Investment Trends Summary GlobalData's “Power Monthly Deal Analysis - July 2013: M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing an …
- 足・足首装具の世界市場About Foot and Ankle DevicesFoot and ankle devices are used for the correction and recuperation of the foot and ankle damaged by injuries or musculoskeletal disorders. The devices can also be used for orthopedic disorders such as osteoarthritis, osteoporosis, bunions, and hammertoes, as well as any congenital or neuropathic condition such as a diabetic foot that requires surgical/non-surgical corr …
- RFID及びバーコードプリンターの世界市場予測（～2022年）“Global RFID and barcode printer market to exhibit significant growth between 2017 and 2022”The RFID and barcode printer market is expected to grow at a CAGR of 5.7% between 2017 and 2022 to reach USD 4.81 billion by 2022. The key driving factors for the growth of this market include the growth of the e-commerce industry; rising demand for extracting data in various manufacturing, retail, transpor …
